aptamer GROUP Logo (WIPO, 29.06.2021)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke aptamer GROUP wurde als Bildmarke am 29.06.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Armillarsphären, Planetarien, astronomische Umlaufbahnen, Atommodelle, molekulare Modelle #Andere Polygone #Briefe, die eine besondere Form des Schreibens darstellen #Farben #Atomare Modelle, molekulare Modelle, Darstellungen von menschlichen, tierischen oder pflanzlichen Zellen #Ein Polygon #Polygone, die andere figurative Elemente enthalten #Serie von Briefen, die verschiedene Formen des Schreibens darstellen #Buchstabenreihen in verschiedenen Dimensionen #Drei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1659777 |
| Länder | 
|
| Basismarke |
Nr. UK00003625640,
13. April 2021
|
| Anmeldedatum | 29. Juni 2021 |
| Ablaufdatum | 29. Juni 2031 |
Markeninhaber
Second Floor, Bio Centre,
Innovation Way, Heslington
GB
Innovation Way, Heslington
GB
Markenvertreter
Calls Wharf,
2 The Calls
GB
Waren und Dienstleistungen
05
Pharmaceutical, medical and veterinary preparations;
medical, veterinary, diagnostic and pharmaceutical
preparations and materials; reagents (medical); chemical
reagents (medical); medical, veterinary, clinical,
diagnostic and pharmaceutical reagents, agents, chemicals,
materials, substances and preparations; medical, clinical,
diagnostic and pharmaceutical reagents, agents, chemicals,
materials, substances and preparations for medical and
veterinary use; optimised aptamer molecules for medical and
veterinary use; medical and veterinary diagnostic reagents
and assays for testing of body fluids; medical and
veterinary diagnostic test strips; diagnostic biomarker
reagents for medical and veterinary purposes; reagents and
media for medical and veterinary diagnostic or treatment
purposes; nucleic acids for medical, veterinary, diagnostic
and pharmaceutical purposes; nucleic acid sequences for
medical, veterinary, diagnostic and pharmaceutical purposes;
diagnostic testing kits (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
diagnostic reagents for medical and veterinary use for sale
in kit form; diagnostic kits comprising specimen receptors
and reagents for medical, veterinary and diagnostic testing;
medical and veterinary diagnostic reagents and assays for
testing of fluids
10
Medical and veterinary apparatus, instruments, equipment,
tools and devices; diagnostic, examination and monitoring
apparatus, instruments, equipment, tools and devices (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations); medical and veterinary
diagnostic apparatus, instruments, equipment, tools and
devices; diagnostic apparatus, instruments, equipment, tools
and devices for medical, veterinary and pharmaceutical
testing; diagnostic apparatus, instruments, equipment, tools
and devices for medical and veterinary purposes; medical and
veterinary diagnostic apparatus, instruments, equipment,
tools and devices for testing for viruses; apparatus,
instruments, equipment, tools and devices for carrying out
diagnostic tests for medical and veterinary purposes;
diagnostic testing kits (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
parts and fittings for all the aforesaid goods
42
Research and development services (term considered too vague
by the International Bureau - Rule 13 (2) (b) of the
Regulations); design and development of diagnostic
apparatus, instruments, equipment, tools and devices;
research, design and development in the field of diagnostic
preparations; research, design and development of reagents;
research, design and development of aptamer reagents;
research, design and development of aptamer reagents for
integration into diagnostic platforms; research, design and
development of reagents for therapeutic applications;
research, design and development of aptamer reagents for
therapeutic applications; custom development of reagents;
custom development of aptamer reagents; optimsation of
aptamer molecules (term considered too vague by the
International Bureau - Rule 13 (2) (b) of the Regulations);
research, design and development of nucleic acids for
medical, veterinary, diagnostic and pharmaceutical purposes;
research, design and development of nucleic acid sequences
for medical, veterinary, diagnostic and pharmaceutical
purposes laboratory testing services; laboratory services
for analytical testing; design and development of testing
and analysis methods; preparation of biological samples for
testing and analysis in research laboratories; medical and
veterinary research services; medical and veterinary
laboratory services; scientific research and investigations
for medical and veterinary purposes; analysis of human and
animal tissues and samples for medical and veterinary
research; biological research, clinical research, medical
research and veterinary research; provision of information
and data relating to medical and veterinary research and
development; information and advisory services in respect of
the aforementioned services
44
Medical, veterinary and diagnostic services; medical and
veterinary testing services; medical and veterinary testing
for diagnostic or treatment purposes; medical and veterinary
analysis services for diagnostic and treatment purposes;
medical and veterinary testing services relating to
diagnosis and treatment; medical and veterinary analysis
services information and advisory services in respect of the
aforementioned services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 28. Juli 2023 | 2023/31 Gaz | RAW: Limitation | |
| 19. Juni 2023 | 2023/25 Gaz | MX | Ablehnung |
| 15. Mai 2023 | 2023/20 Gaz | KR | Ablehnung |
| 04. Mai 2023 | 2023/19 Gaz | VN | Ablehnung |
| 16. April 2023 | 2023/16 Gaz | RU | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 30. März 2023 | 2023/13 Gaz | JP | Ablehnung |
| 01. März 2023 | 2023/9 Gaz | CN | Ablehnung |
| 21. Februar 2023 | 2023/11 Gaz | SG | Ablehnung |
| 19. Januar 2023 | 2023/4 Gaz | EM | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 05. Oktober 2022 | 2022/40 Gaz | BR | Ablehnung |
| 26. August 2022 | 2022/37 Gaz | NZ | Ablehnung |
| 22. August 2022 | 2022/34 Gaz | RU | Ablehnung |
| 11. Juli 2022 | 2022/37 Gaz | RAW: Limitation | |
| 15. Juni 2022 | 2022/24 Gaz | US | Ablehnung |
| 06. Juni 2022 | 2022/23 Gaz | IN | Ablehnung |
| 11. Mai 2022 | 2022/20 Gaz | AU | Ablehnung |
| 11. Mai 2022 | 2022/20 Gaz | EM | Ablehnung |
| 29. Juni 2021 | 2022/16 Gaz | GB | Eintragung |
ID: 141659777